Your browser doesn't support javascript.
loading
Development and Evaluation of a Prediction Model for Ascertaining Rheumatic Heart Disease Status in Administrative Data.
Bond-Smith, D; Seth, R; de Klerk, N; Nedkoff, L; Anderson, M; Hung, J; Cannon, J; Griffiths, K; Katzenellenbogen, J M.
Afiliação
  • Bond-Smith D; School of Population and Global Health, The University of Western Australia, Perth, Australia.
  • Seth R; School of Population and Global Health, The University of Western Australia, Perth, Australia.
  • de Klerk N; School of Population and Global Health, The University of Western Australia, Perth, Australia.
  • Nedkoff L; Telethon Kids Institute, Perth, Australia.
  • Anderson M; School of Population and Global Health, The University of Western Australia, Perth, Australia.
  • Hung J; Queensland Health, Brisbane, Australia.
  • Cannon J; School of Population and Global Health, The University of Western Australia, Perth, Australia.
  • Griffiths K; School of Population and Global Health, The University of Western Australia, Perth, Australia.
  • Katzenellenbogen JM; Telethon Kids Institute, Perth, Australia.
Clin Epidemiol ; 12: 717-730, 2020.
Article em En | MEDLINE | ID: mdl-32753974
BACKGROUND: Previous research has raised substantial concerns regarding the validity of the International Statistical Classification of Diseases and Related Health Problems (ICD) codes (ICD-10 I05-I09) for rheumatic heart disease (RHD) due to likely misclassification of non-rheumatic valvular disease (non-rheumatic VHD) as RHD. There is currently no validated, quantitative approach for reliable case ascertainment of RHD in administrative hospital data. METHODS: A comprehensive dataset of validated Australian RHD cases was compiled and linked to inpatient hospital records with an RHD ICD code (2000-2018, n=7555). A prediction model was developed based on a generalized linear mixed model structure considering an extensive range of demographic and clinical variables. It was validated internally using randomly selected cross-validation samples and externally. Conditional optimal probability cutpoints were calculated, maximising discrimination separately for high-risk versus low-risk populations. RESULTS: The proposed model reduced the false-positive rate (FPR) from acute rheumatic fever (ARF) cases misclassified as RHD from 0.59 to 0.27; similarly for non-rheumatic VHD from 0.77 to 0.22. Overall, the model achieved strong discriminant capacity (AUC: 0.93) and maintained a similar robust performance during external validation (AUC: 0.88). It can also be used when only basic demographic and diagnosis data are available. CONCLUSION: This paper is the first to show that not only misclassification of non-rheumatic VHD but also of ARF as RHD yields substantial FPRs. Both sources of bias can be successfully addressed with the proposed model which provides an effective solution for reliable RHD case ascertainment from hospital data for epidemiological disease monitoring and policy evaluation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Epidemiol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Epidemiol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Nova Zelândia